To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...
CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...
This week, Svante Pääbo, Nobel Prize winner for sequencing the Neanderthal genome, is visiting Estonia. In an interview with ...
The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...